Erythrocyte SOD activity is significantly reduced in patients with lung cancer compared to that in healthy individuals, with a further decline noted in advanced disease stages, suggesting a systemic antioxidant deficiency associated with cancer progression [41]. Here, SOD1 is linked to lung carcinoma.